Primary Immunodeficiencies are a growing group of over 400 inborn errors of immunity that range in severity from life-threatening disorders presenting in infancy to less severe disorders diagnosed in adulthood. Most patients with primary immunodeficiencies present with recurrent or chronic infections. Some disorders impact essential immunologic pathways and result in susceptibility to opportunistic organisms, whereas other disorders may cause susceptibility to a very narrow number of pathogens with a broad age of presentation. The clinical presentation is variable and includes severe or unusual infections, autoimmune diseases and malignanciesPatients with many forms of primary immunodeficiencies are at increased risk for malignancies secondary to a number of different factors, including immune dysregulation, genetic predisposition, radiation sensitivity and impaired viral clearance.
The Igenomix Primary Immunodeficiency Precision Panel can be used for an accurate and directed diagnosis as well as differential diagnosis of recurrent infections ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.
The clinical utility of this panel is:
Tangye, S., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., & Etzioni, A. et al. (2020). Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal Of Clinical Immunology, 40(1), 24-64. doi: 10.1007/s10875-019-00737-x
Bonilla, F., Bernstein, I., Khan, D., Ballas, Z., Chinen, J., & Frank, M. et al. (2005). Practice parameter for the diagnosis and management of primary immunodeficiency. Annals Of Allergy, Asthma & Immunology, 94(5), S1-S63. doi: 10.1016/s1081-1206(10)61142-8
Milner, J., & Holland, S. (2013). The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nature Reviews Immunology, 13(9), 635-648. doi: 10.1038/nri3493
Aguilar, C., Malphettes, M., Donadieu, J., Chandesris, O., Coignard-Biehler, H., & Catherinot, E. et al. (2014). Prevention of Infections During Primary Immunodeficiency. Clinical Infectious Diseases, 59(10), 1462-1470. doi: 10.1093/cid/ciu646
Kebudi, R., Kiykim, A., & Sahin, M. K. (2019). Primary Immunodeficiency and Cancer in Children; A Review of the Literature. Current pediatric reviews, 15(4), 245–250. https://doi.org/10.2174/1573396315666190917154058
Chinn, I. K., Chan, A. Y., Chen, K., Chou, J., Dorsey, M. J., Hajjar, J., Jongco, A. M., 3rd, Keller, M. D., Kobrynski, L. J., Kumanovics, A., Lawrence, M. G., Leiding, J. W., Lugar, P. L., Orange, J. S., Patel, K., Platt, C. D., Puck, J. M., Raje, N., Romberg, N., Slack, M. A., … Walter, J. E. (2020). Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology. The Journal of allergy and clinical immunology, 145(1), 46–69. https://doi.org/10.1016/j.jaci.2019.09.009
